Treatment after venous thromboembolism (VTE) as captured in observational healthcare data generally follows the Dutch guidelines, except for the duration of low-molecular-weight heparin treatment, which was longer than recommended. This was concluded in a study recently published in Jacobs Journal of Hematology. Initial anticoagulant treatment after VTE was determined using the PHARMO Database Network in the Netherlands. The observation of shorter anticoagulant treatment among patients with recurrent VTE compared to patients with no recurrence may indicate that anticoagulant treatment was not optimal for these patients.

To read more, please click here.

Share this article